Diagnostik von messenger Ribonukleinsäure (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) impfassoziierten Myokarditiden – ein systematischer Review

Federspiel, Jan M.; Ramsthaler, Frank; Kettner, Mattias; Mall, Gerhard

doi:10.1007/s00194-022-00587-9

Cited by 1 publication

(1 citation statement)

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In most cases, these side effects are mild and short-lived. However, in a number of patients adverse reactions to anti-SARS-CoV-2 vaccines can persist and be severe or even life-threatening and fatal [ 2 ]. If adverse reactions last longer than four weeks, one speaks of the long post-COVID vaccination syndrome (LPCVS) in analogy to the long-COVID syndrome [ 3 , 4 ].…”

Section: Introductionmentioning

confidence: 99%

A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose

Finsterer¹

2022

Cureus

View full text Add to dashboard Cite

It is undisputed that anti-SARS-CoV-2 vaccines can have side effects. Long post-COVID vaccination syndrome (LPCVS) is one of them and is often neglected. It persists 11 months after the third mRNA-1273 (Moderna) vaccine dose has not been reported. Our patient is a 39-year-old male with a largely uneventful previous history who developed severe adverse reactions immediately after the third dose of the mRNA-1273 (Moderna) vaccine. In addition to brief fever, headache, flickering eyes, skin rashes, tiredness, disorientation, dizziness (brain fog), tiredness, impaired thinking and concentration, and emotional disorders occurred as a result. Cerebral MRI showed non-specific white matter lesions in a frontotemporal distribution. Some of the immune parameters were deflected. Non-steroidal anti-inflammatory drugs, antihistamines, sartans, and statins have occasionally provided temporary relief. In conclusion, LPCVS is a definite complication of anti-SARS-CoV-2 vaccinations and can severely impact the quality of life and lead to disability. Despite extensive work-up, a clear cause for the long-term neuro-cognitive deficits cannot be identified. Symptomatic treatment can provide some relief. Patients with LPCVS should be taken seriously and treated appropriately.

show abstract

Section: Introductionmentioning

confidence: 99%

A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose

Finsterer¹

2022

Cureus

View full text Add to dashboard Cite

show abstract

Diagnostik von messenger Ribonukleinsäure (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) impfassoziierten Myokarditiden – ein systematischer Review

Cited by 1 publication

References 73 publications

A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose

A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose

Contact Info

Product

Resources

About